Krishne Gowda Selected Research

Krishne Gowda Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 01/2013
6	Carcinogenesis 01/2022 - 08/2016
3	Mouth Neoplasms (Oral Cancer) 01/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 11/2021 - 02/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 10/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 08/2014
2	Multiple Myeloma 01/2020 - 01/2017
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2019
2	Leukemia 01/2020 - 10/2015
2	Oral Leukoplakia 01/2019 - 12/2017
1	Infections 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Papillomavirus Infections 01/2021
1	Hyperplasia 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Acne Vulgaris 06/2019
1	Chloracne 06/2019
1	Inflammation (Inflammations) 12/2017
1	Gout 12/2017
1	Edema (Dropsy) 12/2017
1	Shock 12/2017
1	Leukoplakia 08/2016
1	Autoimmune Diseases (Autoimmune Disease) 06/2015
1	Skin Diseases (Skin Disease) 05/2015
1	Rheumatoid Arthritis 02/2014
1	Disease Progression 02/2014
1	Melanoma (Melanoma, Malignant) 01/2013
1	Human Influenza (Influenza) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

10	dibenzo(a,l)pyreneIBA 01/2022 - 07/2015
6	SmokeIBA 01/2022 - 01/2018
4	DNA AdductsIBA 01/2022 - 12/2017
4	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 10/2017
4	CarcinogensIBA 01/2021 - 01/2017
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2019 - 02/2014
3	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 07/2015
3	EnzymesIBA 02/2020 - 01/2012
3	LigandsIBA 06/2019 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	4-oxo-5,7,10,13,16,19-docosahexaenoic acidIBA 11/2021 - 02/2015
2	Docosahexaenoic AcidsIBA 11/2021 - 02/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2012
2	Oxidoreductases (Dehydrogenase)IBA 02/2020 - 01/2020
2	AldehydesIBA 02/2020 - 01/2020
2	Protein Isoforms (Isoforms)IBA 02/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
2	Casein Kinase II (Casein Kinase 2)IBA 01/2020 - 10/2015
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 10/2015
2	Biological ProductsIBA 01/2018 - 10/2006
2	marinopyrrole AIBA 08/2014 - 01/2013
1	Benzo(a)pyreneIBA 01/2022
1	Lipoxygenase (Lipoxygenase-1)IBA 11/2021
1	Dinoprostone (PGE2)FDA Link 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	15-hydroxyprostaglandin dehydrogenaseIBA 11/2021
1	Viral DNAIBA 01/2021
1	Viral ProteinsIBA 01/2021
1	silmitasertibIBA 01/2020
1	Aldehyde DehydrogenaseIBA 01/2020
1	Environmental CarcinogensIBA 01/2020
1	CholesterolIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	IsatinIBA 01/2020
1	LipidsIBA 06/2019
1	Polychlorinated Dibenzodioxins (TCDD)IBA 06/2019
1	N'-nitrosonornicotine (nitrosonornicotine)IBA 01/2019
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 11/2018
1	dibenzo(a,l)pyrene diol epoxideIBA 01/2018
1	PowdersIBA 01/2018
1	Epoxy Compounds (Epoxides)IBA 01/2018
1	Anthocyanins (Anthocyanin)IBA 12/2017
1	trans-1,2-dihydro-1,2-naphthalenediolIBA 12/2017
1	SGA 360IBA 12/2017
1	LipopolysaccharidesIBA 12/2017
1	Uric Acid (Urate)IBA 12/2017
1	TubulinIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 08/2016
1	2',7'-dichlorodihydrofluorescein diacetateIBA 08/2016
1	Therapeutic UsesIBA 10/2015
1	navitoclaxIBA 05/2015
1	venetoclaxIBA 05/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2015
1	Phenobarbital (Luminal)FDA Link 02/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014
1	pyoluteorinIBA 01/2014
1	Apoptosis Regulatory ProteinsIBA 01/2013
1	ABT-737IBA 01/2013
1	CaspasesIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2012
1	Exonucleases (3' 5' Exonuclease)IBA 01/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007
1	Co-Repressor ProteinsIBA 01/2007

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2015
1	Chemoprevention 01/2019